title: Support of the infectivity of hepatitis delta virus particles by the envelope proteins of different genotypes of hepatitis B virus.
abstract: This study examined how the envelope proteins of 25 variants of hepatitis B virus (HBV) genotypes A to I support hepatitis delta virus (HDV) infectivity. The assembled virions bore the same HDV ribonucleoprotein and differed only by the HBV variant-specific envelope proteins coating the particles. The total HDV yields varied within a 122-fold range. A residue Y (position 374) in the HDV binding site was identified as critical for HDV assembly. Virions that bound antibodies, which recognize the region that includes the HBV matrix domain and predominantly but not exclusively immunoprecipitate the PreS1-containing virions, were termed PreS1*-HDVs. Using in vitro infection of primary human hepatocytes (PHH), we measured the specific infectivity (SI), which is the number of HDV genomes/cell produced by infection and normalized by the PreS1*-MOI, which is the multiplicity of infection that reflects the number of PreS1*-HDVs per cell in the inoculum used. The SI values varied within a 160-fold range and indicated a probable HBV genotype-specific trend of D > B > E > A in supporting HDV infectivity. Three variants, of genotypes B, C, and D, supported the highest SI values. We also determined the normalized index (NI) of infected PHH, which is the percentage of HDV-infected hepatocytes normalized by the PreS1*-MOI. Comparison of the SI and NI values revealed that, while a particular HBV variant may facilitate the infection of a relatively significant fraction of PHH, it may not always result in a considerable number of genomes that initiated replication after entry. The potential implications of these findings are discussed in the context of the mechanism of attachment/entry of HBV and HDV.
  
  
  OBJECTIVE
  The study advances the understanding of the mechanisms of (i) attachment and entry of HDV and HBV and (ii) transmission of HDV infection/disease.
authors.affiliation: Department of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
authors.forename: Natalia
authors.initials: N
authors.lastname: Freitas
authors.forename: Kenji
authors.initials: K
authors.lastname: Abe
authors.forename: Celso
authors.initials: C
authors.lastname: Cunha
authors.forename: Stephan
authors.initials: S
authors.lastname: Menne
authors.forename: Severin O
authors.initials: SO
authors.lastname: Gudima
mesh_terms: D017931:DNA Primers / Q000235:genetics; D005455:Fluorescent Antibody Technique; D005822:Genetic Vectors; D005838:Genotype; D006515:Hepatitis B virus / Q000235:genetics / Q000378:metabolism*; D003698:Hepatitis Delta Virus / Q000472:pathogenicity*; D022781:Hepatocytes; D006801:Humans; D047468:Immunoprecipitation; D014759:Viral Envelope Proteins / Q000235:genetics / Q000378:metabolism*; D014771:Virion / Q000235:genetics* / Q000472:pathogenicity*; D014774:Virulence; D019065:Virus Assembly / Q000235:genetics*; D053585:Virus Attachment; D053586:Virus Internalization
chemical_list: D017931:DNA Primers; D014759:Viral Envelope Proteins